Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Comment by mdjbrownon Jun 17, 2024 10:42am

RE:RE:RE:Buybacks are possible

QC1, would it not be prudent then for the company to conserve cash, and wait a couple quarters to ensure their profitability projections are on point, before spending a third of the treasury on a NCIB ...more  
Comment by QContinuum1on Jun 17, 2024 9:40am

RE:RE:Buybacks are possible

Not claiming that they are is a different stage than LABS, but certainly if LABS are accurate in their profitability projections, then the risk of doing a buyback with some of the treasury is also low ...more  
Comment by mdjbrownon Jun 17, 2024 9:31am

RE:Buybacks are possible

QC1, Verano appears to be in a much better stage of revenue growth making a NCIB shareholder friendly with minimal risk.  Not sure Medipharm can say the same at the moment ...more  
Post by QContinuum1on Jun 17, 2024 9:14am

Buybacks are possible

CHICAGO, June 17, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that its Board of ...more  
Comment by QContinuum1on Jun 16, 2024 1:31pm

RE:RE:Management gave no follow up details

  Saying a government entity is slow is like saying the sun rises in the east.  That said, it's of less importance that whatever LABS is waiting on and much more important that they ...more  
Comment by mdjbrownon Jun 16, 2024 12:35pm

RE:Management gave no follow up details

piduks, is it possible ANVISA is holding up the announcement party? I havent seen any press releases out of Brazil lately from ANVISA regarding CBD approvals for any companies, and yet corporations ...more  
Comment by Solid1on Jun 16, 2024 10:16am

RE:Management gave no follow up details

Well, he's not entirely wrong when it comes to public relations. Medipharm Labs has a lot to do in the background and does not disclose any information to its shareholders... while the share price ...more  
Post by pidukson Jun 15, 2024 10:34pm

Management gave no follow up details

after they received the second drug approval from Brazil contrary to what senior management indicated publicly they would do once the second approval was received.   Could that indicate a ...more  
Post by pidukson Jun 15, 2024 11:41am

Global distribution includes China and rest of world.

This is something Medipharm Labs does not have irregardless of their existing business alliances.   SK Capital Partners could enhance their monetization of privately held Apotex by way of ...more  
Comment by QContinuum1on Jun 14, 2024 5:57pm

RE:RE:RE:M&A activity s/b with SK Capital Partners

Insta-Ignore.....it's the only thing that helps. Guy went from astral plains and rainbows to hard bash overnight. As I've said, you can hate on and be disappointed in a lot of things LABS if ...more  
Comment by subaru1on Jun 14, 2024 1:59pm

RE:RE:Science & Health

It has been now 25 months that we are in the range of $0,07 and $0,10 and there is always someone to feed the $0,08 it becomes unbeleivable. We are at the end of the second qrt and no news about any ...more  
Comment by Redwine12345on Jun 14, 2024 1:57pm

RE:RE:M&A activity s/b with SK Capital Partners

mdjbrown, His motives are clear. IMHO, what we see is a big accumulation going on and they use what ever they can to squeeze your shares. Science is on side with MPL. Management is doing a great job ...more  
Comment by CADInvestor12on Jun 14, 2024 9:20am

RE:RE:M&A activity s/b with SK Capital Partners

It's unfortunate that people like piducks fill these boards with garbage, and distract. I'm not advocating that anyone take investment advice from stockhouse but you should be able to have a ...more  
Comment by okgonowon Jun 14, 2024 9:18am

RE:RE:Science & Health

hey piduks the above was meant for you by the way!! i Voted today and you convinced me that the YES to all is the way to go forward here !!! you dont seem to have a good grasp of MPL and where its ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities